期刊文献+

胰腺癌组织中细胞凋亡与增殖相关性的研究 被引量:1

Relationship between apoptosis and proliferation in pancreatic carcinoma
原文传递
导出
摘要 目的 通过对胰腺癌组织中细胞凋亡与增殖相关性的研究 ,探讨其在胰腺癌发生发展中的作用。方法 采用原位末端标记、增殖细胞核抗原免疫组织化学染色和HE染色的方法对 32例胰腺癌和 14例慢性胰腺炎组织中细胞凋亡指数 (AI)、增殖指数 (PI)和分裂细胞指数 (MI)进行检测。结果 胰腺癌组织中的AI(3.37± 2 .38)、PI(46 .6 8± 2 .2 9)、MI(0 .31± 0 .12 )均明显高于慢性胰腺炎(0 .5 1± 0 .2 3、5 .0 8± 2 .82、0 .0 6± 0 .0 3,P <0 .0 0 1) ,癌组织的PI/AI(2 1.16± 17.44 )高于慢性胰腺炎(9 .6 0± 2 .15 ,P <0 .0 5 ) ,癌组织中AI与PI呈负相关 ,随肿瘤进展 ,PI/AI值增大。结论 细胞增殖增多、细胞凋亡相对减少 ,共同促进胰腺癌的发生发展。 Objective\ To investigate the role of apoptosis in pancreatic carcinoma by studying the relationship between apoptosis and proliferation. Methods\ The apoptotic index (AI), PCNA index (PI) and mitotic index (MI) in situ in 32 cases of pancreatic carcinoma and 14 cases of chronic pancreatitis were detected by in situ end labeling (ISEL), PCNA immunohistochemical staining and HE staining. Results\ The mean AI(3.37± 2.38 ),PI( 46.68 ±2.29) and MI(0.31±0.12) in pancreatic carcinoma were significantly higher than those in chronic pancreatitis (0.51±0.23,5.08±2.82 and 0.06±0.03 respectively, P <0.001). The ratio of PI to AI (21.16±17.44) in the pancreatic carcinoma was higher than that in chronic pancreatitis (9.60±2.15, P < 0.05 ). There was a negative relationship between AI and PI in pancreatic carcinoma. Conclusion\ The reduction of apoptotic cells and the increase in proliferative cells play an important role in the development of pancreatic carcinoma.
作者 张元 钱家勤
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2000年第2期107-108,共2页 Chinese Journal of Experimental Surgery
关键词 细胞凋亡 增殖细胞核抗原 胰腺肿瘤 相关性 Carcinoma, pancreatic \ Apoptosis \ Proliferation
  • 相关文献

参考文献1

共引文献5

同被引文献10

  • 1郭俊超,赵玉沛,Dale E.Bockman,廖泉,Michael W.Muller,Helmut Friess.胰腺癌细胞起源和演进的新实验证据[J].中华肝胆外科杂志,2005,11(5):320-323. 被引量:13
  • 2黄庆先,王国斌,孙念峰,王春友.CDC25B在胰腺癌中的表达及其临床意义[J].中华实验外科杂志,2006,23(1):24-25. 被引量:5
  • 3Sebastian B, Kakizuka A, Hunter A. Cdc25 M2 activation of cyclindependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci USA, 1993,90:3521-3524.
  • 4Gasparotto D, Maestro R, Piccinin S, et al. Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res,1997,57:2366- 2368.
  • 5Kudo Y, Yasui W, Ue T, et al. overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas. Jpn J Cancer Res, 1997,88:947-952.
  • 6Hernandez S, Bessa X, Bea S, et al. Differential expression of cdc25 cell-cycle-activating phosphatases in human colorectal carcinoma. Lab Invest,2001,81:465-473.
  • 7Ngan ES, Hashimoto Y, Ma YQ, et al. Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer. Oncogene,2003,22 : 734-739.
  • 8Bardeesy N. DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer,2002.2:897-909.
  • 9Galaktionov K, Beach D. specific activation of cdc25 tyrosine phophatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell, 1991,67 : 1181-1194.
  • 10Kudo Y, Yasui W, Yamamoto S, et al. overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas. Jpn J Cancer Res, 1997,88:947-952.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部